LIDDS Inkomsten in het verleden

Verleden criteriumcontroles 0/6

LIDDS's earnings have been declining at an average annual rate of -4.3%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 14.4% per year.

Belangrijke informatie

-4.3%

Groei van de winst

14.4%

Groei van de winst per aandeel

Biotechs Groei van de industrie0.7%
Inkomstengroei-14.4%
Rendement op eigen vermogen-331.6%
Nettomarge-150,588.2%
Volgende winstupdate21 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

Here's Why We're Watching LIDDS' (STO:LIDDS) Cash Burn Situation

May 26
Here's Why We're Watching LIDDS' (STO:LIDDS) Cash Burn Situation

Here's Why We're Watching LIDDS' (STO:LIDDS) Cash Burn Situation

Dec 15
Here's Why We're Watching LIDDS' (STO:LIDDS) Cash Burn Situation

Will LIDDS (STO:LIDDS) Spend Its Cash Wisely?

Jul 19
Will LIDDS (STO:LIDDS) Spend Its Cash Wisely?

Here's Why We're Not Too Worried About LIDDS' (STO:LIDDS) Cash Burn Situation

Mar 08
Here's Why We're Not Too Worried About LIDDS' (STO:LIDDS) Cash Burn Situation

We're Not Very Worried About LIDDS' (STO:LIDDS) Cash Burn Rate

Nov 23
We're Not Very Worried About LIDDS' (STO:LIDDS) Cash Burn Rate

Opbrengsten en kosten

Hoe LIDDS geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

OM:LIDDS Opbrengsten, kosten en inkomsten (SEK Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 240-2650
31 Mar 240-3180
31 Dec 230-40110
30 Sep 230-31140
30 Jun 231-34160
31 Mar 231-37160
31 Dec 222-37160
30 Sep 224-37150
30 Jun 224-36140
31 Mar 224-36130
31 Dec 214-37110
30 Sep 212-41100
30 Jun 211-40100
31 Mar 211-3580
31 Dec 200-3270
30 Sep 200-28-120
30 Jun 200-29-60
31 Mar 200-3210
31 Dec 190-3170
30 Sep 190-28240
30 Jun 198-15140
31 Mar 198-980
31 Dec 189-2140
30 Sep 188-110
30 Jun 181-860
31 Mar 181-730
31 Dec 171-730
30 Sep 171-730
30 Jun 170-710
31 Mar 170-730
31 Dec 160-730
30 Sep 160-660
30 Jun 160-660
31 Mar 160-770
31 Dec 150-880
30 Sep 150-880
30 Jun 150-880
31 Mar 150-880
31 Dec 140-770
30 Sep 140-660
30 Jun 140-660
31 Mar 140-440
31 Dec 130-440

Kwaliteitswinsten: LIDDS is currently unprofitable.

Groeiende winstmarge: LIDDS is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: LIDDS is unprofitable, and losses have increased over the past 5 years at a rate of 4.3% per year.

Versnelling van de groei: Unable to compare LIDDS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: LIDDS is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).


Rendement op eigen vermogen

Hoge ROE: LIDDS has a negative Return on Equity (-331.56%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden